Isomerization of an Antimicrobial Peptide Broadens Antimicrobial Spectrum to Gram-Positive Bacterial Pathogens

Chiara Falciani, Luisa Lozzi, Simona Pollini, Vincenzo Luca, Veronica Carnicelli, Jlenia Brunetti, Barbara Lelli, Stefano Bindi, Silvia Scali, Antonio Di Giulio, Gian Maria Rossolini, Maria Luisa Mangoni, Luisa Bracci, Alessandro Pini

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

The branched M33 antimicrobial peptide was previously shown to be very active against Gram-negative bacterial pathogens, including multidrug-resistant strains. In an attempt to produce back-up molecules, we synthesized an M33 peptide isomer consisting of D-aminoacids (M33-D). This isomeric version showed 4 to 16-fold higher activity against Gram-positive pathogens, including Staphylococcus aureus and Staphylococcus epidermidis, than the original peptide, while retaining strong activity against Gram-negative bacteria. The antimicrobial activity of both peptides was influenced by their differential sensitivity to bacterial proteases. The better activity shown by M33-D against S. aureus compared to M33-L was confirmed in biofilm eradication experiments where M33-L showed 12% activity with respect to M33-D, and in vivo models where Balb-c mice infected with S. aureus showed 100% and 0% survival when treated with M33-D and M33-L, respectively. M33-D appears to be an interesting candidate for the development of novel broad-spectrum antimicrobials active against bacterial pathogens of clinical importance.

Original languageEnglish
Article numbere46259
JournalPLoS One
Volume7
Issue number10
DOIs
Publication statusPublished - Oct 2 2012

Fingerprint

isomerization
antimicrobial peptides
Pathogens
Isomerization
Staphylococcus aureus
anti-infective agents
peptides
Peptides
pathogens
Staphylococcus epidermidis
Gram-negative bacteria
biofilm
isomers
Biofilms
proteinases
Gram-Negative Bacteria
Isomers
Bacteria
Peptide Hydrolases
mice

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Falciani, C., Lozzi, L., Pollini, S., Luca, V., Carnicelli, V., Brunetti, J., ... Pini, A. (2012). Isomerization of an Antimicrobial Peptide Broadens Antimicrobial Spectrum to Gram-Positive Bacterial Pathogens. PLoS One, 7(10), [e46259]. https://doi.org/10.1371/journal.pone.0046259

Isomerization of an Antimicrobial Peptide Broadens Antimicrobial Spectrum to Gram-Positive Bacterial Pathogens. / Falciani, Chiara; Lozzi, Luisa; Pollini, Simona; Luca, Vincenzo; Carnicelli, Veronica; Brunetti, Jlenia; Lelli, Barbara; Bindi, Stefano; Scali, Silvia; Di Giulio, Antonio; Rossolini, Gian Maria; Mangoni, Maria Luisa; Bracci, Luisa; Pini, Alessandro.

In: PLoS One, Vol. 7, No. 10, e46259, 02.10.2012.

Research output: Contribution to journalArticle

Falciani, C, Lozzi, L, Pollini, S, Luca, V, Carnicelli, V, Brunetti, J, Lelli, B, Bindi, S, Scali, S, Di Giulio, A, Rossolini, GM, Mangoni, ML, Bracci, L & Pini, A 2012, 'Isomerization of an Antimicrobial Peptide Broadens Antimicrobial Spectrum to Gram-Positive Bacterial Pathogens', PLoS One, vol. 7, no. 10, e46259. https://doi.org/10.1371/journal.pone.0046259
Falciani, Chiara ; Lozzi, Luisa ; Pollini, Simona ; Luca, Vincenzo ; Carnicelli, Veronica ; Brunetti, Jlenia ; Lelli, Barbara ; Bindi, Stefano ; Scali, Silvia ; Di Giulio, Antonio ; Rossolini, Gian Maria ; Mangoni, Maria Luisa ; Bracci, Luisa ; Pini, Alessandro. / Isomerization of an Antimicrobial Peptide Broadens Antimicrobial Spectrum to Gram-Positive Bacterial Pathogens. In: PLoS One. 2012 ; Vol. 7, No. 10.
@article{d762f30a8bb24134b9b0330212ee675e,
title = "Isomerization of an Antimicrobial Peptide Broadens Antimicrobial Spectrum to Gram-Positive Bacterial Pathogens",
abstract = "The branched M33 antimicrobial peptide was previously shown to be very active against Gram-negative bacterial pathogens, including multidrug-resistant strains. In an attempt to produce back-up molecules, we synthesized an M33 peptide isomer consisting of D-aminoacids (M33-D). This isomeric version showed 4 to 16-fold higher activity against Gram-positive pathogens, including Staphylococcus aureus and Staphylococcus epidermidis, than the original peptide, while retaining strong activity against Gram-negative bacteria. The antimicrobial activity of both peptides was influenced by their differential sensitivity to bacterial proteases. The better activity shown by M33-D against S. aureus compared to M33-L was confirmed in biofilm eradication experiments where M33-L showed 12{\%} activity with respect to M33-D, and in vivo models where Balb-c mice infected with S. aureus showed 100{\%} and 0{\%} survival when treated with M33-D and M33-L, respectively. M33-D appears to be an interesting candidate for the development of novel broad-spectrum antimicrobials active against bacterial pathogens of clinical importance.",
author = "Chiara Falciani and Luisa Lozzi and Simona Pollini and Vincenzo Luca and Veronica Carnicelli and Jlenia Brunetti and Barbara Lelli and Stefano Bindi and Silvia Scali and {Di Giulio}, Antonio and Rossolini, {Gian Maria} and Mangoni, {Maria Luisa} and Luisa Bracci and Alessandro Pini",
year = "2012",
month = "10",
day = "2",
doi = "10.1371/journal.pone.0046259",
language = "English",
volume = "7",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "10",

}

TY - JOUR

T1 - Isomerization of an Antimicrobial Peptide Broadens Antimicrobial Spectrum to Gram-Positive Bacterial Pathogens

AU - Falciani, Chiara

AU - Lozzi, Luisa

AU - Pollini, Simona

AU - Luca, Vincenzo

AU - Carnicelli, Veronica

AU - Brunetti, Jlenia

AU - Lelli, Barbara

AU - Bindi, Stefano

AU - Scali, Silvia

AU - Di Giulio, Antonio

AU - Rossolini, Gian Maria

AU - Mangoni, Maria Luisa

AU - Bracci, Luisa

AU - Pini, Alessandro

PY - 2012/10/2

Y1 - 2012/10/2

N2 - The branched M33 antimicrobial peptide was previously shown to be very active against Gram-negative bacterial pathogens, including multidrug-resistant strains. In an attempt to produce back-up molecules, we synthesized an M33 peptide isomer consisting of D-aminoacids (M33-D). This isomeric version showed 4 to 16-fold higher activity against Gram-positive pathogens, including Staphylococcus aureus and Staphylococcus epidermidis, than the original peptide, while retaining strong activity against Gram-negative bacteria. The antimicrobial activity of both peptides was influenced by their differential sensitivity to bacterial proteases. The better activity shown by M33-D against S. aureus compared to M33-L was confirmed in biofilm eradication experiments where M33-L showed 12% activity with respect to M33-D, and in vivo models where Balb-c mice infected with S. aureus showed 100% and 0% survival when treated with M33-D and M33-L, respectively. M33-D appears to be an interesting candidate for the development of novel broad-spectrum antimicrobials active against bacterial pathogens of clinical importance.

AB - The branched M33 antimicrobial peptide was previously shown to be very active against Gram-negative bacterial pathogens, including multidrug-resistant strains. In an attempt to produce back-up molecules, we synthesized an M33 peptide isomer consisting of D-aminoacids (M33-D). This isomeric version showed 4 to 16-fold higher activity against Gram-positive pathogens, including Staphylococcus aureus and Staphylococcus epidermidis, than the original peptide, while retaining strong activity against Gram-negative bacteria. The antimicrobial activity of both peptides was influenced by their differential sensitivity to bacterial proteases. The better activity shown by M33-D against S. aureus compared to M33-L was confirmed in biofilm eradication experiments where M33-L showed 12% activity with respect to M33-D, and in vivo models where Balb-c mice infected with S. aureus showed 100% and 0% survival when treated with M33-D and M33-L, respectively. M33-D appears to be an interesting candidate for the development of novel broad-spectrum antimicrobials active against bacterial pathogens of clinical importance.

UR - http://www.scopus.com/inward/record.url?scp=84867024731&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867024731&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0046259

DO - 10.1371/journal.pone.0046259

M3 - Article

C2 - 23056272

AN - SCOPUS:84867024731

VL - 7

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 10

M1 - e46259

ER -